Myricetin Improves Impaired Nerve Functions in Experimental Diabetic Rats

Diabetic peripheral neuropathy (DPN) is considered as one of the most important complications of diabetes mellitus. At present, effective treatments that might improve the damaged neurological function in DPN are sorely needed. As myricetin has been proved to possess excellent neuroprotective and an...

Full description

Bibliographic Details
Main Authors: Junxiong Ma, Jun Liu, Yu Chen, Hailong Yu, Liangbi Xiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.915603/full
_version_ 1818473682194923520
author Junxiong Ma
Jun Liu
Yu Chen
Hailong Yu
Liangbi Xiang
author_facet Junxiong Ma
Jun Liu
Yu Chen
Hailong Yu
Liangbi Xiang
author_sort Junxiong Ma
collection DOAJ
description Diabetic peripheral neuropathy (DPN) is considered as one of the most important complications of diabetes mellitus. At present, effective treatments that might improve the damaged neurological function in DPN are sorely needed. As myricetin has been proved to possess excellent neuroprotective and antioxidant effects, it might have therapeutic potential for DPN. Therefore, the purpose of our study was to detect the potential beneficial effect of myricetin on DPN. A single dose of 50 mg/kg of streptozotocin was applied in rats for the establishment of diabetic models. Different doses of myricetin (0.5 mg/kg/day, 1.0 mg/kg/day, and 2.0 mg/kg/day) were intraperitoneally injected for 2 weeks from the 21st day after streptozotocin injection. After the final myricetin injection, behavioral, electrophysiological, biochemical, and protein analyses were performed. In the present study, myricetin significantly ameliorated diabetes-induced impairment in sensation, nerve conduction velocities, and nerve blood flow. In addition, myricetin significantly reduced the generation of advanced glycation end-products (AGEs) and reactive oxygen species (ROS), and elevated Na+, K+-ATPase activity and antioxidant activities in nerves in diabetic animals. Additional studies revealed that myricetin significantly raised the hydrogen sulfide (H2S) levels, and elevated the expression level of heme oxygenase-1 (HO-1) as well as nuclear factor-E2-related factor-2 (Nrf2) in diabetic rats. In addition, myricetin has the capability of decreasing plasma glucose under diabetic conditions. The findings in our present study collectively indicated that myricetin could restore the impaired motor and sensory functions under diabetic conditions. The Nrf2-dependent antioxidant action and the capability of decreasing plasma glucose might be the underlying mechanisms for the beneficial effect of myricetin on impaired neural functions. Our study showed the therapeutic potential of myricetin in the management of DPN.
first_indexed 2024-04-14T04:25:34Z
format Article
id doaj.art-d0160802416047dd9b86363efa2beed8
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-14T04:25:34Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-d0160802416047dd9b86363efa2beed82022-12-22T02:12:19ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-07-011310.3389/fendo.2022.915603915603Myricetin Improves Impaired Nerve Functions in Experimental Diabetic RatsJunxiong MaJun LiuYu ChenHailong YuLiangbi XiangDiabetic peripheral neuropathy (DPN) is considered as one of the most important complications of diabetes mellitus. At present, effective treatments that might improve the damaged neurological function in DPN are sorely needed. As myricetin has been proved to possess excellent neuroprotective and antioxidant effects, it might have therapeutic potential for DPN. Therefore, the purpose of our study was to detect the potential beneficial effect of myricetin on DPN. A single dose of 50 mg/kg of streptozotocin was applied in rats for the establishment of diabetic models. Different doses of myricetin (0.5 mg/kg/day, 1.0 mg/kg/day, and 2.0 mg/kg/day) were intraperitoneally injected for 2 weeks from the 21st day after streptozotocin injection. After the final myricetin injection, behavioral, electrophysiological, biochemical, and protein analyses were performed. In the present study, myricetin significantly ameliorated diabetes-induced impairment in sensation, nerve conduction velocities, and nerve blood flow. In addition, myricetin significantly reduced the generation of advanced glycation end-products (AGEs) and reactive oxygen species (ROS), and elevated Na+, K+-ATPase activity and antioxidant activities in nerves in diabetic animals. Additional studies revealed that myricetin significantly raised the hydrogen sulfide (H2S) levels, and elevated the expression level of heme oxygenase-1 (HO-1) as well as nuclear factor-E2-related factor-2 (Nrf2) in diabetic rats. In addition, myricetin has the capability of decreasing plasma glucose under diabetic conditions. The findings in our present study collectively indicated that myricetin could restore the impaired motor and sensory functions under diabetic conditions. The Nrf2-dependent antioxidant action and the capability of decreasing plasma glucose might be the underlying mechanisms for the beneficial effect of myricetin on impaired neural functions. Our study showed the therapeutic potential of myricetin in the management of DPN.https://www.frontiersin.org/articles/10.3389/fendo.2022.915603/fullmyricetinDPNnociceptionoxidative stressNrf2
spellingShingle Junxiong Ma
Jun Liu
Yu Chen
Hailong Yu
Liangbi Xiang
Myricetin Improves Impaired Nerve Functions in Experimental Diabetic Rats
Frontiers in Endocrinology
myricetin
DPN
nociception
oxidative stress
Nrf2
title Myricetin Improves Impaired Nerve Functions in Experimental Diabetic Rats
title_full Myricetin Improves Impaired Nerve Functions in Experimental Diabetic Rats
title_fullStr Myricetin Improves Impaired Nerve Functions in Experimental Diabetic Rats
title_full_unstemmed Myricetin Improves Impaired Nerve Functions in Experimental Diabetic Rats
title_short Myricetin Improves Impaired Nerve Functions in Experimental Diabetic Rats
title_sort myricetin improves impaired nerve functions in experimental diabetic rats
topic myricetin
DPN
nociception
oxidative stress
Nrf2
url https://www.frontiersin.org/articles/10.3389/fendo.2022.915603/full
work_keys_str_mv AT junxiongma myricetinimprovesimpairednervefunctionsinexperimentaldiabeticrats
AT junliu myricetinimprovesimpairednervefunctionsinexperimentaldiabeticrats
AT yuchen myricetinimprovesimpairednervefunctionsinexperimentaldiabeticrats
AT hailongyu myricetinimprovesimpairednervefunctionsinexperimentaldiabeticrats
AT liangbixiang myricetinimprovesimpairednervefunctionsinexperimentaldiabeticrats